Innovation
9 patent families (2 granted) — focus: Human necessities; filing pace dormant. Cited 941 times.
Investor mix
8 investors on record; lead investors include Novartis Venture Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 63% |
| Private equity | 1 | 13% |
| Bank & private debt | 1 | 13% |
| Other / undisclosed | 1 | 13% |